A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses

Journal of Veterinary Pharmacology and Therapeutics

Volumn 21, Issue 1, 1998, Pages 24-33

  Goodrich, L R ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELTENAC; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; GASTROINTESTINAL TOXICITY; HISTOLOGY; HORSE; HYPOPROTEINEMIA; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; STOMACH ULCER; TOXICITY TESTING;

ANILINE COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APPETITE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HORSES; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; MALE; MOUTH; ORCHIECTOMY; STOMACH; STOMACH ULCER; THIOPHENES;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 0031891920     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1998.00813.x     Document Type: Article

References (5)

1. Allen, A. & Garner, A. (1980) Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut, 21, 249-262.
2. Bolton, J.P. & Cohen. M.M. (1979) The effect of prostaglandin E2, 16-methyl prostaglandin E2 and metiamide on established canine gastric mucosal barrier damage. Surgery. 85, 333-338.
3. Cheung, L.Y. (1981) Effect of topical, 16.16-dimethyl prostaglandin E2 on aspirin-induced disruption of gastric permeability barrier in dogs. Prostaglandins, 21 (supplement), 125-129.
4. Cohen, M.M. & Pollett, J.M. (1976) Prostaglandin E2 prevents aspirin and indomethacin damage to human gastric mucosa. Surgical Forum, 27. 400-401.
5. Collins. L.G. & Tyler, D.E. (1984) Phenylbutazone toxicosis in the horse: a clinical study. Journal of American Veterinary Medical Association. 184, 689-703.